Related Funds
Fund Name | Location |
415 CAPITAL Management | Bavaria, Germany, Oberhaching |
Black Horse Capital Advisors | - |
Dingxiang Capital | Beijing, Beijing, China |
East Africa Capital Partners | Kenya, Nairobi, Nairobi Area |
Framgia | - |
Glengary Ventures | Beachwood, Ohio, United States |
Guoqian Venture Capital | China, Haimen, Jiangsu |
Heyihui Capital | Beijing, Beijing, China |
Huashan Touzi | Beijing, Beijing, China |
Just Eat | England, London, United Kingdom |
Kiraboshi Bank | Chiyoda, Japan |
MedCity News | Cleveland, Ohio, United States |
Mobai Capital | China, Guangdong, Guangzhou |
Patni Group | India, Maharashtra, Mumbai |
Pittsburgh Equity Partners | Pennsylvania, Pittsburgh, United States |
Swedbank | Lithuania, Vilniaus Apskritis, Vilnius |
Telekom Investment Pool | - |
Zedcrest Capital Limited | Lagos, Lagos, Nigeria |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Formo | $61M | 09 Sep 2024 | Berlin, Berlin, Germany | ||
OrsoBio | $67M | 06 Sep 2024 | Palo Alto, California, United States | ||
Scorpion Therapeutics | $150M | 16 Jul 2024 | Boston, Massachusetts, United States | ||
Endeavor BioMedicines | $132M | 24 Apr 2024 | California, United States | ||
Obsidian Therapeutics | $160M | 03 Apr 2024 | Cambridge, Massachusetts, United States | ||
Mirador Therapeutics | $400M | 21 Mar 2024 | San Diego, California, United States | ||
Odyssey Therapeutics | $101M | 05 Dec 2023 | Cambridge, Massachusetts, United States | ||
Septerna | $150M | 11 Jul 2023 | San Francisco, California, United States | ||
Odyssey Therapeutics | $168M | 13 Oct 2022 | Cambridge, Massachusetts, United States |
– ShouTi Inc. announced the close of a $100m Series B financing round.
– The round was led by BVF Partners. Additional new investors include Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Lilly Asia Ventures, Monashee Capital, Sage Partners, Stork Capital, Surveyor Capital (a Citadel company), TCG X, Terra Magnum Capital Partners, Woodline Partners, and co-founder and strategic partner Schrödinger.
– Existing investors also participated in the financing, including Eight Roads, F-Prime Capital Partners, Qiming Venture Partners, Sequoia Capital China, TF Capital and Wuxi AppTec.
– SmartNews, a news aggregation website and app, raised $230m in Series F funding.
– The round was led by Princeville Capital and Woodline Partners, and joined by JIC Venture Growth Investments, Green Co-Invest Investment, and Yamauchi-No.10 Family Office in Japan.
– Existing investors participated in this round including ACA Investments and SMBC Venture Capital.
– The company plans to develop more features for its U.S. audience that will focus on consumer health and safety.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Formo | $61M | 09 Sep 2024 | Berlin, Berlin, Germany | ||
OrsoBio | $67M | 06 Sep 2024 | Palo Alto, California, United States | ||
Scorpion Therapeutics | $150M | 16 Jul 2024 | Boston, Massachusetts, United States | ||
Endeavor BioMedicines | $132M | 24 Apr 2024 | California, United States | ||
Obsidian Therapeutics | $160M | 03 Apr 2024 | Cambridge, Massachusetts, United States | ||
Mirador Therapeutics | $400M | 21 Mar 2024 | San Diego, California, United States | ||
Odyssey Therapeutics | $101M | 05 Dec 2023 | Cambridge, Massachusetts, United States | ||
Septerna | $150M | 11 Jul 2023 | San Francisco, California, United States | ||
Odyssey Therapeutics | $168M | 13 Oct 2022 | Cambridge, Massachusetts, United States |